← Back to Search

IPACK block for Anterior Cruciate Ligament Rupture

Phase 4

Waitlist Available

Led By Eric J Strauss, MD

Research Sponsored by NYU Langone Health

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, month 6 post-operation visit

Awards & highlights

Study Summary

This trial found that adding an adductor canal block to IPACK infiltration may improve post-operative pain and reduce opioid consumption in patients undergoing ACL reconstruction.

Eligible Conditions

Anterior Cruciate Ligament (ACL) Rupture

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, month 6 post-operation visit

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, month 6 post-operation visit

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, month 6 post-operation visit for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Opioid Utilization in First 24 Hours Post-Surgery

Secondary outcome measures

Change in Knee Injury and Osteoarthritis Outcome Score- Physical Function Short Form (KOOS-PS)

Change in Kujala Scale Score

Change in Tegner Activity Scale (TAS) Score

+6 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Participants receiving IPACK blockExperimental Treatment1 Intervention

Patients in this study group will receive the standard of care adductor canal block composed of 15 mL of Bupivacaine (0.25%). And receive the additional IPACK block performed using 20 mL of Bupivacaine (0.25%) injected into the interspace between the popliteal artery and capsule of the knee.

Group II: Standard of care groupActive Control1 Intervention

Patients in the control group will receive the standard of care adductor canal block composed of 15 mL of Bupivacaine (0.25%).

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

IPACK block

2022

Completed Phase 4

~190

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

NYU Langone HealthLead Sponsor

1,367 Previous Clinical Trials

839,619 Total Patients Enrolled

Eric J Strauss, MDPrincipal InvestigatorNYU Langone Health

1 Previous Clinical Trials

50 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are individuals below the age of sixty qualified to partake in this medical experiment?

"The eligibility criteria for this trial necessitates that volunteers must be between 18 and 75 years of age. For those younger than 18, there are 19 trials available while 49 studies can be found by seniors over 65."

Answered by AI

How many individuals have contributed to this clinical trial thus far?

"Confirmed. Clinicaltrials.gov shows that this trial, which was originally listed on July 11th 2022, is still open for enrollment and looking to accept 100 patients at a single site."

Answered by AI

To whom does this experimental protocol extend?

"The eligibility requirements for this clinical trial mandate that participants must have experienced an anterior cruciate ligament rupture and be between 18 and 75 years of age. The research team is hoping to recruit around 100 qualified individuals."

Answered by AI

Are there any openings for participants in this health experiment?

"Affirmative. Clinicaltrials.gov's records confirm that this medical trial, originally posted on July 11th 2022, is currently recruiting participants. The goal is to enrol 100 individuals from one site."

Answered by AI

Has the IPACK block been given a regulatory thumbs up by the FDA?

"There is substantial evidence confirming the safety of IPACK block, leading to a score of 3 on our scale. This treatment has also been approved for use in Phase 4 clinical trials."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Adductor Canal Block and IPACK Block vs. Isolated Adductor Canal Block for Post-Operative Analgesia Following ACL Reconstruction With Bone Patellar Tendon Bone Autograft:

2022. "Adductor Canal Block and IPACK Block vs. Isolated Adductor Canal Block for Post-Operative Analgesia Following ACL Reconstruction With Bone Patellar Tendon Bone Autograft:". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05286307.